In a first pilot study, Albert et al. compared the diagnostic accuracy of TSPO PET with [18F]-GE-180 with respect to that of MRI for the delineation of both newly diagnosed (n = 7) and post-therapy recurrent (n = 4) IDH wild-type GBM [22]. Here, IDH1 is linked to glioblastoma.